CVI是一家成立于2007年的生物医药高科技研究公司，在 美 国 Palo Alto 和中国上海均设有实验室及办公室。CVI—Cardiovascular Innovation, 蕴含着我们的使命：研究、开发与血脂异常相关疾病的新药，包括心血管疾病、脂肪肝及代谢综合症，造福于广大患者。
CVI Pharmaceuticals (CVI) is a privately-held biopharmaceutical company established in 2007. CVI stands for Cardiovascular Innovation. The mission of CVI is to discover, develop, and commercialize novel orally administered drugs to treat hyperlipidemia-associated maladies, including cardiovascular disease, hepatic steatosis and metabolic syndrome. CVI has research facilities in Palo Alto, California and Shanghai, China.